These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 18474263)
1. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels. Ortega A; Carretero J; Obrador E; Estrela JM Nitric Oxide; 2008 Sep; 19(2):107-14. PubMed ID: 18474263 [TBL] [Abstract][Full Text] [Related]
2. Glutathione in cancer biology and therapy. Estrela JM; Ortega A; Obrador E Crit Rev Clin Lab Sci; 2006; 43(2):143-81. PubMed ID: 16517421 [TBL] [Abstract][Full Text] [Related]
3. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. Benlloch M; Ortega A; Ferrer P; Segarra R; Obrador E; Asensi M; Carretero J; Estrela JM J Biol Chem; 2005 Feb; 280(8):6950-9. PubMed ID: 15561710 [TBL] [Abstract][Full Text] [Related]
4. Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. Carretero J; Obrador E; Esteve JM; Ortega A; Pellicer JA; Sempere FV; Estrela JM J Biol Chem; 2001 Jul; 276(28):25775-82. PubMed ID: 11313348 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. Ortega A; Ferrer P; Carretero J; Obrador E; Asensi M; Pellicer JA; Estrela JM J Biol Chem; 2003 Oct; 278(41):39591-9. PubMed ID: 12881529 [TBL] [Abstract][Full Text] [Related]
6. Glutathione in metastases: From mechanisms to clinical applications. Estrela JM; Ortega A; Mena S; Sirerol JA; Obrador E Crit Rev Clin Lab Sci; 2016 Aug; 53(4):253-67. PubMed ID: 26754151 [TBL] [Abstract][Full Text] [Related]
7. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197 [TBL] [Abstract][Full Text] [Related]
8. Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium. Ortega AL; Carretero J; Obrador E; Gambini J; Asensi M; Rodilla V; Estrela JM J Biol Chem; 2003 Apr; 278(16):13888-97. PubMed ID: 12578841 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. Ferrer P; Asensi M; Priego S; Benlloch M; Mena S; Ortega A; Obrador E; Esteve JM; Estrela JM J Biol Chem; 2007 Feb; 282(5):2880-90. PubMed ID: 17135264 [TBL] [Abstract][Full Text] [Related]
10. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity. Obrador E; Valles SL; Benlloch M; Sirerol JA; Pellicer JA; Alcácer J; Coronado JA; Estrela JM PLoS One; 2014; 9(5):e96466. PubMed ID: 24802641 [TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver. Mendoza L; Carrascal T; De Luca M; Fuentes AM; Salado C; Blanco J; Vidal-Vanaclocha F Hepatology; 2001 Aug; 34(2):298-310. PubMed ID: 11481615 [TBL] [Abstract][Full Text] [Related]
13. Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Carretero J; Obrador E; Anasagasti MJ; Martin JJ; Vidal-Vanaclocha F; Estrela JM Clin Exp Metastasis; 1999; 17(7):567-74. PubMed ID: 10845555 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. Benlloch M; Mena S; Ferrer P; Obrador E; Asensi M; Pellicer JA; Carretero J; Ortega A; Estrela JM J Biol Chem; 2006 Jan; 281(1):69-79. PubMed ID: 16263711 [TBL] [Abstract][Full Text] [Related]
15. Effects of glutathione depletion on cadmium-induced metallothionein synthesis, cytotoxicity, and proto-oncogene expression in cultured rat myoblasts. Shimizu M; Hochadel JF; Waalkes MP J Toxicol Environ Health; 1997 Aug; 51(6):609-21. PubMed ID: 9242231 [TBL] [Abstract][Full Text] [Related]
16. Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats. Todorova VK; Harms SA; Kaufmann Y; Luo S; Luo KQ; Babb K; Klimberg VS Breast Cancer Res Treat; 2004 Dec; 88(3):247-56. PubMed ID: 15609127 [TBL] [Abstract][Full Text] [Related]
17. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Anasagasti MJ; Martin JJ; Mendoza L; Obrador E; Estrela JM; McCuskey RS; Vidal-Vanaclocha F Hepatology; 1998 May; 27(5):1249-56. PubMed ID: 9581678 [TBL] [Abstract][Full Text] [Related]
18. Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice. Obrador E; Benlloch M; Pellicer JA; Asensi M; Estrela JM J Biol Chem; 2011 May; 286(18):15716-27. PubMed ID: 21393247 [TBL] [Abstract][Full Text] [Related]
19. Induction of glutathione content in murine melanocytes after transformation with c-H-ras oncogene. Thrall BD; Meadows GG Carcinogenesis; 1991 Jul; 12(7):1319-23. PubMed ID: 1712678 [TBL] [Abstract][Full Text] [Related]
20. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species. Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]